1. Home
  2. FONR vs RANI Comparison

FONR vs RANI Comparison

Compare FONR & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fonar Corporation

FONR

Fonar Corporation

HOLD

Current Price

$18.89

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.06

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FONR
RANI
Founded
1978
2012
Country
United States
United States
Employees
535
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
126.8M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
FONR
RANI
Price
$18.89
$1.06
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.50
AVG Volume (30 Days)
54.3K
903.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
57.14
EPS
1.16
N/A
Revenue
$104,351,318.00
$1,633,000.00
Revenue This Year
N/A
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
$16.29
N/A
Revenue Growth
1.43
58.85
52 Week Low
$13.62
$0.39
52 Week High
$18.95
$3.87

Technical Indicators

Market Signals
Indicator
FONR
RANI
Relative Strength Index (RSI) 61.80 54.54
Support Level $18.31 $0.46
Resistance Level $18.95 $1.10
Average True Range (ATR) 0.04 0.09
MACD -0.01 0.01
Stochastic Oscillator 65.83 69.27

Price Performance

Historical Comparison
FONR
RANI

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: